TABLE 2.
Clinicopathological characteristics of BLCA patients in the discovery cohort. (TCGA cohort and Fudan University Shanghai Cancer Center cohort)
| Characteristics | FUSCC cohort (N = 49) | TCGA cohort | |
|---|---|---|---|
|
Training cohort (N = 246) |
Testing cohort (N = 163) |
||
| N (%) | |||
| Age | |||
| <70 years | 30(61.2) | 126(51.2) | 91(55.8) |
| ≥70 years | 19(38.8) | 120(48.8) | 72(44.2) |
| Gender | |||
| Male | 35 (71.4) | 178(72.3) | 124(76.1) |
| Female | 14 (28.6) | 68(27.7) | 39(23.9) |
| Tumour stage | |||
| I‐II | 26(56.5) | 74(30.3) | 57(35.0) |
| III‐IV | 20(43.5) | 170(69.7) | 106(65.0) |
| T stage a | |||
| T1 ‐ T2 | 25(54.3) | 68(30.1) | 53(35.6) |
| T3 ‐ T4 | 21(45.7) | 158(69.9) | 96(64.4) |
| N stage a | |||
| N0‐1 | 36(78.2) | 169(78.2) | 113(75.3) |
| N2‐3 | 10(21.8) | 47(21.8) | 37(24.7) |
| M stage a | |||
| M0 | 35(77.7) | 111(93.3) | 88(96.7) |
| M1 | 10(22.3) | 8(6.7) | 3(3.2) |
| Grade | |||
| Low | 14(31.8) | 13(5.4) | 7(4.3) |
| High | 30(68.2) | 231(94.6) | 155(95.7) |
| Subtype | |||
| Papillary | 7(16.7) | 78(31.7) | 53(33.5) |
| Non‐Papillary | 35(83.3) | 168(68.3) | 105(66.5) |
a
TNM scoring system: Tumour size, lymph nodes affected, metastases.